Clinical trial
A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5 Percent Minoxidil Foam in the Treatment of Androgenetic Alopecia in Males
NCT00151515 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer and Personal Products Worldwide as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5 Percent Minoxidil Foam in the Treatment of Androgenetic Alopecia in Males
- Lead sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- July 31, 2004
- Enrollment
- 352 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
androgenetic alopecia